Adam Mence, Senior Brand Manager at L&R Medical UK, discusses the challenges of lower limb wound management and the benefits of driving evidence-based and self-care interventions.
Driven by personal loss, this healthcare leader shares how their organisation (SAH Diagnostics) partners with the NHS, combining innovation and clinical excellence to reduce NHS cancer backlogs and improve patient outcomes in an exclusive interview with Open Access Government.
Shane Dineen, Managing Director at Archus, discusses some of the key challenges facing healthcare systems. He emphasises the importance of fostering a mindset that prioritises people’s best interests to enable sustainable solutions that improve care quality and patient welfare.
Ed Hutchison, Clinical Solutions Specialist at Altera Digital Health and practising NHS Doctor, explains how improving patient flow with the help of digital solutions can support both clinicians and patients, optimising care delivery and outcomes.
NHS England is gearing up for a significant upgrade in its electronic patient records (EPR) systems across various Health and Justice facilities throughout England.
In today's demanding clinical landscape, integrating generative AI tools like ClinicalKey AI is essential for enhancing efficiency and improving patient care in primary care settings.
Lorna Rothery spoke to stroke researcher and ESO Fellow Rajiv Advani about the wider psychological impacts of stroke, how AI could be harnessed to improve post-stroke care for patients, and the importance of increasing symptom awareness.
The past ten years have seen significant progress in cancer care, detecting cancers earlier and managing them more successfully and less invasively on a global scale.
Digital health platforms offer vast potential for enhancing the lives of PD patients and caregivers. A study in the Journal of Nutrition Education and Behavior emphasises their role in improving healthcare services.
Kate Fry, CEO of America’s Blood Centers, discusses the essential role of blood products and transfusion medicine in the U.S. and the efforts to ensure blood’s safety and availability.
The vast majority of genetic diseases remains beyond possibilities of treatment with research continuing to be able to offer therapies to the affected patients.
Simone Schoenwaelder from Australia’s Heart Research Institute tells us about exciting advancements in stroke research and care that could dramatically improve clinical outcomes for patients.
The promise of connected care has expanded the opportunities for how clinicians and patients interact, offering care from a distance and creating a shift towards more accessible systems.
